Company Filing History:
Years Active: 1998
Title: Innovations of Choi Yong Moon
Introduction
Choi Yong Moon is an accomplished inventor based in Towaco, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective solutions for central nervous system disorders.
Latest Patents
Choi Yong Moon holds a patent for "Carbamate compounds having N-substituted thiocarbamoyl group and process." This patent describes a specific compound, 3-N-substituted thiocarbamoyl-2-phenyl-1,3-propanediol carbamate, which is effective for the prophylaxis and treatment of various central nervous system disorders, including nervous muscular pain, epilepsy, and cerebral apoplexy. The structural formula of the compound is represented as follows: ##STR1##. The compound features R₁ and R₂, which can be independently selected from a group consisting of hydrogen, lower alkyl containing 1 to 8 carbon atoms, and 5 to 7-membered aliphatic cyclic compounds that may include two or fewer nitrogen or oxygen atoms directly unconnected. Importantly, R₁ and R₂ cannot both be hydrogen, and the total number of carbon atoms in R₁ and R₂ must range from 1 to 16.
Career Highlights
Choi Yong Moon is associated with Yukong Limited, where he continues to innovate and develop new compounds. His work has the potential to significantly impact the treatment of neurological conditions, showcasing his dedication to advancing medical science.
Collaborations
Choi collaborates with talented individuals in his field, including Han Dong Il and Kim Hyung Cheol. These partnerships enhance the research and development process, leading to more effective solutions in the medical field.
Conclusion
Choi Yong Moon's contributions to the field of chemistry and his innovative patent demonstrate his commitment to improving healthcare through scientific advancements. His work is a testament to the importance of research and collaboration in the pursuit of medical breakthroughs.